Basel, Basel, Switzerland
I am a Project Manager in the pharmaceutical industry, combining a hands-on mentality with deep experience in matrix leadership. My systematic approach and commitment to continuous innovation empower me to solve complex challenges. At F. Hoffmann-La Roche, I serve as a Project Manager for DS Manufacturing, guiding tech transfer projects from the clinical phase through to commercial launch. My expertise is in large molecules and ADCs, where I drive efficient process implementation to accelerate the delivery of innovative drugs to patients.
■ Biomanufacturing ■ Upstream and Downstream Processing ■ Manufacturing Science and Technology ■ Single use technology ■ Project management
Basel Biotech Manufacturing - Production Enabling DSP ■ Master thesis: „Characterization of a scale down model for purification of immunotherapeutic monoclonal antibodies“ ■ Implementation and characterization of a mAb purification scale down model under GMP conditions ■ Analysis of product quality using several bioanalytical methods (e.g. HPLC, qPCR, ECLIA) ■ Evaluation of the statistical equivalence of the scale down model and production scale processes based on product-quality and process performance Further activities: ■ Coordination and performance of product stability and validation studies ■ Writing and management of GMP documents (e.g. SOPs) ■ Performance of leachables and extractables studies
Lead Identification and Chemical Realization ■ Development of screening methods for the production and identification of new natural metabolite target molecules e.g. antibiotics ■ Development of bacterial and fungal cell culture growth models ■ Ministration and management of one of the world-wide biggest private cell strain bank
Translational Med & Early Clinical: ■ Characterization of pre-clinical diabetes biomarker ■ Analysis of biomarker-protein-sequence alignments from different mammalian species ■ Performing bioanalytical methods (ELISA, qPCR) Lead Identification and Chemical Realization ■ Development of screening methods for the production and identification of new natural metabolite target molecules e.g. antibiotics ■ Development of bacterial and fungal cell culture growth models ■ Ministration and management of one of the world-wide biggest private cell strain bank